{
    "2021-10-11": [
        [
            {
                "time": "",
                "original_text": "益方生物第三代EGFR抑制剂BPI-D0316项目与贝达药业授权合作",
                "features": {
                    "keywords": [
                        "益方生物",
                        "第三代EGFR抑制剂",
                        "BPI-D0316",
                        "贝达药业",
                        "授权合作"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "创新药企益方生物“自研+合作”模式加速发展",
                "features": {
                    "keywords": [
                        "创新药企",
                        "益方生物",
                        "自研+合作",
                        "加速发展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}